JAZZ
Jazz Pharmaceuticals plc
Stock
$235.67+2.66 (+1.14%)Close Oct 2, 2026
- Research and development, 2025
- $783M
- YoY, 2025
- −11.5%
- 5-year CAGR
- +18.5%
- 10-year CAGR
- +19.2%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $783M | −11.5% |
| 2024 | $884M | +4.0% |
| 2023 | $850M | +43.9% |
| 2022 | $590M | +16.7% |
| 2021 | $506M | +50.8% |
| 2020 | $335M | +11.9% |
| 2019 | $300M | +32.3% |
| 2018 | $227M | +14.2% |
| 2017 | $198M | +22.3% |
| 2016 | $162M | +20.0% |
| 2015 | $135M | +58.8% |
| 2014 | $85M | +104.6% |
| 2013 | $42M | +103.3% |
| 2012 | $20M | +45.0% |
| 2011 | $14M | −44.9% |
| 2010 | $26M | −29.9% |
| 2009 | $37M | — |